Scientists Explore Hormone Replacement Therapy for Alzheimer’s
Alzheimer’s disease is more prevalent among women than men: Two-thirds of the 5.5 million people in the U.S. living with the disease are women….
Alzheimer’s disease is more prevalent among women than men: Two-thirds of the 5.5 million people in the U.S. living with the disease are women….
With the changes that occur as you age, it can be easy to think of growing older as a steady decline. While some changes…
Type 2 diabetes is linked to a two-fold or higher increased risk of developing Alzheimer’s disease. Researchers presented findings at Neuroscience 2019, the annual…
While forgetfulness and cognitive decline are the main defining symptoms of dementia or Alzheimer’s, the conditions are also often riddled with behavioral issues and…
What’s happening inside the brain during and after a traumatic brain injury is still an active area of research. While nerve damage from hits…
Building empathy among caregivers and healthcare providers is an important aspect of treating dementia, and virtual reality (VR) offers a way for people to…
Antipsychotic drugs are most commonly used to treat mental health conditions like schizophrenia or bipolar disorder, but they’re also often prescribed to patients with…
The link between cardiovascular health and neurodegenerative diseases like Alzheimer’s is well-established. Now, a new study finds that oral anticoagulants — drugs that help…
As research into Alzheimer’s advances, scientists are shifting their focus from beta-amyloid accumulation to inflammation as a main driver of the disease. In a…
In a massive effort involving dozens of researchers and long-term care facilities, the National Institute on Aging (NIA) has awarded a $53.4 million grant…
A drugmaker agreed to pay $116 million in penalties to settle charges by the U.S. government that it sought to improperly influence doctors in…
Diet has been shown to play a role in staving off a variety of disorders, from cardiovascular disease to dementia. A new study pinpoints…
Tacrine, also known as its brand name Cognex, was the first drug approved by the FDA for the treatment of Alzheimer’s disease. At the…
Though we may not realize it, we each have our own personal walking style and pace. Now researchers are finding that a person’s walking…
Beta-amyloid plaques are one of the most studied aspects of the development of Alzheimer’s disease. But as knowledge about this incredibly complex disease grows,…